Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

In a significant move aimed at enhancing access to essential respiratory care, AstraZeneca recently announced plans to broaden its savings programs across its entire US inhaled respiratory ...